Microbiotix, Inc.
✓ Verified ManufacturerAbout
Microbiotix Inc is a clinical-stage biopharmaceutical company based in Worcester Massachusetts specializing in the discovery and development of innovative small molecule drugs to combat serious infectious diseases and multi-drug resistant pathogens. The company operates as a research-driven pharmaceutical manufacturer focused on addressing critical unmet medical needs through proprietary drug development technologies. The company has established itself as a leader in nucleoside analog therapeutics with their flagship compound MBX-400 serving as a potent dual DNA polymerase and kinase inhibitor specifically targeting human cytomegalovirus. This novel therapeutic has successfully completed Phase 1 clinical testing demonstrating the company's capability to advance treatments from discovery through clinical development phases. Microbiotix operates sophisticated drug discovery and development capabilities enabling the design synthesis and clinical advancement of targeted pharmaceutical compounds. Their manufacturing expertise encompasses small molecule drug development with specialized focus on anti-infective therapeutics for resistant pathogens. The Worcester-based facility maintains rigorous pharmaceutical development standards while pursuing breakthrough treatments for infectious diseases that pose significant therapeutic challenges. The company has earned recognition as the top recipient of NIH awards among Massachusetts biotechnology and pharmaceutical companies reflecting their scientific excellence and innovative research capabilities. Through their specialized manufacturing and development platform Microbiotix continues advancing novel pharmaceutical solutions designed to address critical infectious disease treatment gaps in modern medicine.